推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 為進一步加強中藥飲片質(zhì)量監(jiān)管，切實保障公眾用藥安全，助推中藥產(chǎn)業(yè)健康發(fā)展，省藥監(jiān)局三分局在轄區(qū)內(nèi)立足“三個結(jié)合”開展中藥飲片專項整治工作。
一是專項整治與普法宣傳結(jié)合。檢查過程中執(zhí)法人員向企業(yè)講解新《藥品管理法》相關(guān)規(guī)定，使企業(yè)充分了解新法處罰力度的嚴(yán)厲性。同時，督促企業(yè)加強自我管理，嚴(yán)格落實主體責(zé)任，做到合法規(guī)范生產(chǎn)經(jīng)營。
二是專項整治與監(jiān)督抽檢結(jié)合。通過篩選近年來各地檢驗情況確定重點品種，對在產(chǎn)的中藥飲片生產(chǎn)企業(yè)，確保每家抽樣不低于5批次;對中藥飲片摻雜使假、染色增重、霉?fàn)€變質(zhì)、硫熏、農(nóng)藥殘留、以次充好等突出問題進行靶向性抽檢，為中藥飲片質(zhì)量集中整治提供技術(shù)支撐。
三是專項整治與稽查辦案結(jié)合。執(zhí)法人員在檢查過程中堅決落實“四個最嚴(yán)”要求，按照《藥品管理法》規(guī)定，實施監(jiān)管與執(zhí)法辦案的有效銜接機制，發(fā)現(xiàn)違法違規(guī)行為，依法嚴(yán)查重處。
